Back
Protagonist Therapeutics Vs. Entrada Therapeutics Industry Stock Comparison
Sell
45
PTGX
Protagonist Therapeutics
Last Price:
46.45
Seasonality Move:
11.46%
Buy
65
TRDA
Entrada Therapeutics
Last Price:
18.85
Seasonality Move:
-34.62%
Sell
45
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $46.46. The Score for PTGX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- PTGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
Entrada Therapeutics (TRDA)
is a Buy
Is Entrada Therapeutics a Buy, Sell or Hold?
- The current Entrada Therapeutics [TRDA] share price is $18.80. The Score for TRDA is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- TRDA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $46.46
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing buying pressure, which is a positive indicator for future bullish movement.
TRDA Stock Price Chart
What is Entrada Therapeutics's stock price today?
-
The Entrada Therapeutics share price today is $18.80
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRDA is experiencing buying pressure, which is a positive indicator for future bullish movement.
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.01 | Sell |
| Relative Strength Index (14 RSI): | 57.05 | Buy |
| Chaikin Money Flow: | 782176 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.22 - 47.9) | Buy |
| Bollinger Bands (100): | (38.27 - 46.31) | Buy |
TRDA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.33 | Buy |
| Relative Strength Index (14 RSI): | 57.68 | Buy |
| Chaikin Money Flow: | 68474 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.1 - 19.1) | Buy |
| Bollinger Bands (100): | (15.08 - 17.94) | Buy |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.58 | Buy |
| 20-day SMA: | 44.66 | Buy |
| 50-day SMA: | 45.25 | Buy |
| 200-day SMA: | 35.78 | Buy |
| 8-day EMA: | 42.72 | Buy |
| 20-day EMA: | 43.78 | Buy |
| 50-day EMA: | 44.02 | Buy |
| 200-day EMA: | 36.88 | Buy |
TRDA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.36 | Buy |
| 20-day SMA: | 18.36 | Buy |
| 50-day SMA: | 17.01 | Buy |
| 200-day SMA: | 15.21 | Buy |
| 8-day EMA: | 18.37 | Buy |
| 20-day EMA: | 18.21 | Buy |
| 50-day EMA: | 17.42 | Buy |
| 200-day EMA: | 15.87 | Buy |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.45 per share, and a decrease next year of $3.44 per share.
Entrada Therapeutics Earnings Growth & TRDA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.09 per share, and a decrease next year of $4.11 per share.
Protagonist Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Entrada Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||